An Open-label, Uncontrolled, Multicentre Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy
An Open-Label, Multicentre Phase 2 Basket Study to Evaluate the Antitumor Activity and Safety of Lenvatinib in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Malignancies.
Single Dose Study Evaluating the Pharmacokinetics and Safety of Intravenous Polymyxin B in Hospitalised Neonates, Children and Adolescents: Global Antibiotic and Research Development Programme
